Figure 4
(a) Overall survival and (b) disease-free survival curves according to LAPTM4B-35 expression (high/low) in lymph node metastases. Patients with high LAPTM4B-35 expression in lymph nodes had a statistically significant worse DFS.
Figure 4 | Scientific Reports
